跳至主要内容
临床试验/ITMCTR2000004085
ITMCTR2000004085招募中未知

Clinical study of eliminating dampness and phlegm treatment for angina pectoris after revascularization of coronary heart disease

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 ?(—)
性别
All

入选标准

  • 1 Age over 18 years;
  • 2 Percutaneous transluminal coronary angioplasty (PTCA) or stent implantation was performed within 1 year
  • 3 2<= rSS Score;
  • 4 consent to Myocardial Contrast Echocardiography;
  • 5 informed consent.

排除标准

  • CARDIOGENIC shock; severe heart failure (Grade IV cardiac function, or lvef <= 40%); patients with severe valvular heart disease; severe hepatic and Renal Impairment (Serum Alanine transaminase > 3 times normal upper limit and/or serum Creatinine >= 265umol/l) ; Patients with acute cerebrovascular disease or severe mental illness; women with active bleeding or severe hematopoietic disorders; Malignant neoplasms or patients with a life expectancy of less than 3 years; women who are pregnant or preparing for pregnancy; women who are breastfeeding; Those who have participated in or are participating in other clinical trials within the last three months; those who refuse to sign an informed consent form, or who have poor adherence and poor likelihood of follow-up.

研究者

发起方
Guangdong Provincial Hospital of Chinese Medicine

相似试验